ResistanceBio

We solve drug resistance for cancer

Y CombinatorWinter 2019InactiveHealthcareTherapeuticsAI-powered Drug Discovery

What they do

Problem

Cancer treatments often fail because tumors develop resistance to drugs.

Solution

Technology that identifies, prevents, or overcomes drug resistance mechanisms in cancer to improve treatment effectiveness.

Who it's for

Oncologists, cancer treatment centers, and pharmaceutical companies developing oncology therapies.

Founders

Nicholas Goldner

CEO/Founder

I have a PhD in molecular cell biology, I figure out how living cells thrive in hostile environments. I'm fascinated by how living organisms, people, organizations, etc. adapt and evolve when faced with hostility. I use these skills to understand which companies, ideas, or projects are most likely to succeed. I'm a technical founder and I enjoy building companies.